Given that the greatly increased statistical power with our 612-case population, our finding highlights the clinical potential of ZNF750 for Chinese ESCC patients and warrant further clinical investigation through prospective randomized clinical trials to confirm the application. Here, ZNF750 is linked to esophageal squamous cell carcinoma.